Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Cascadian Therapeutics, Inc.Listing unverified | Buy | $17.4K | conv 72First in 12mo | SEC | |
Cascadian Therapeutics, Inc.Listing unverified | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Cascadian Therapeutics, Inc.Listing unverified | Buy | $18.8K | conv 89First in 12mo | SEC | |
Cascadian Therapeutics, Inc.Listing unverified | Buy | $6.1K | conv 80First in 12mo | SEC | |
Cascadian Therapeutics, Inc.Listing unverified | Buy | $507 | conv 49First in 12mo | SEC | |
Cascadian Therapeutics, Inc.Listing unverified | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |